HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eytan Ruppin Selected Research

L-Lactate Dehydrogenase (Lactate Dehydrogenase)

12/2021Characterization of HLH-like manifestations as a CRS variant in patients receiving CD22 CAR T cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eytan Ruppin Research Topics

Disease

84Neoplasms (Cancer)
04/2024 - 06/2009
19Melanoma (Melanoma, Malignant)
09/2023 - 07/2018
15COVID-19
12/2023 - 01/2020
12Breast Neoplasms (Breast Cancer)
04/2024 - 06/2009
7Infections
04/2022 - 12/2018
6Lung Neoplasms (Lung Cancer)
04/2024 - 10/2020
6Carcinogenesis
01/2023 - 02/2013
6Neoplasm Metastasis (Metastasis)
01/2022 - 01/2019
5Glioblastoma (Glioblastoma Multiforme)
01/2023 - 12/2015
4Colorectal Neoplasms (Colorectal Cancer)
03/2024 - 12/2017
3Hepatocellular Carcinoma (Hepatoma)
11/2023 - 01/2016
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2023 - 01/2021
2Head and Neck Neoplasms (Head and Neck Cancer)
10/2023 - 01/2023
2Adenocarcinoma of Lung
10/2023 - 01/2023
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2023 - 01/2023
2Glucosephosphate Dehydrogenase Deficiency
03/2023 - 01/2023
2Cytokine Release Syndrome
01/2023 - 12/2021
2Neuroblastoma
01/2023 - 10/2018
2Pulmonary Hypertension
06/2022 - 01/2022
2Disease Progression
06/2022 - 01/2021
2Rectal Neoplasms (Rectal Cancer)
01/2022 - 01/2020
2Triple Negative Breast Neoplasms
01/2021 - 10/2020
2Pancreatic Neoplasms (Pancreatic Cancer)
12/2019 - 12/2010
2Metabolic Diseases (Metabolic Disease)
12/2018 - 09/2008
2Alzheimer Disease (Alzheimer's Disease)
01/2017 - 01/2014
1Multiple Myeloma
04/2024
1Non-Hodgkin Lymphoma (Lymphosarcoma)
03/2024
1Inborn Genetic Diseases (Disease, Hereditary)
02/2024
1Leukemia
12/2023

Drug/Important Bio-Agent (IBA)

13Biomarkers (Surrogate Marker)IBA
03/2024 - 01/2009
12RNA (Ribonucleic Acid)IBA
03/2024 - 01/2017
12Immune Checkpoint InhibitorsIBA
11/2023 - 10/2018
11Proteins (Proteins, Gene)FDA Link
03/2024 - 07/2009
9EnzymesIBA
01/2022 - 09/2008
7Messenger RNA (mRNA)IBA
09/2023 - 12/2018
6VaccinesIBA
06/2022 - 08/2021
6mRNA VaccinesIBA
06/2022 - 08/2021
6BNT162 VaccineIBA
06/2022 - 08/2021
5Transcription Factors (Transcription Factor)IBA
01/2022 - 12/2010
4Ligases (Synthetase)IBA
10/2023 - 12/2020
4Chimeric Antigen ReceptorsIBA
10/2023 - 12/2021
4Glutamine (L-Glutamine)FDA Link
01/2019 - 03/2011
3DNA (Deoxyribonucleic Acid)IBA
02/2024 - 07/2009
3LigandsIBA
09/2023 - 11/2019
3UbiquitinIBA
01/2023 - 12/2020
3Phosphotransferases (Kinase)IBA
11/2022 - 01/2012
3Antiviral Agents (Antivirals)IBA
06/2022 - 09/2021
3CholesterolIBA
04/2022 - 03/2015
3Serine (L-Serine)FDA Link
01/2021 - 11/2012
3MicroRNAs (MicroRNA)IBA
01/2021 - 06/2009
3Amino AcidsFDA Link
12/2019 - 03/2011
3pyrimidineIBA
01/2019 - 11/2015
3ProteomeIBA
12/2018 - 01/2016
3Small Interfering RNA (siRNA)IBA
07/2018 - 09/2015
2NucleotidesIBA
02/2024 - 12/2015
2Immunologic Factors (Immunomodulators)IBA
11/2023 - 01/2022
2purineIBA
10/2023 - 01/2020
2pembrolizumabIBA
10/2023 - 01/2022
2EnlightIBA
09/2023 - 01/2023
2Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA
03/2023 - 01/2023
2Drug CombinationsIBA
01/2023 - 01/2022
2Hemoglobins (Hemoglobin)IBA
06/2022 - 01/2022
2Peptides (Polypeptides)IBA
01/2022 - 01/2021
2AntibodiesIBA
12/2021 - 08/2021
2Immunoglobulin G (IgG)IBA
12/2021 - 08/2021
2Vitamin DFDA LinkGeneric
03/2021 - 01/2021
2Ezetimibe (Zetia)FDA Link
03/2021 - 01/2021
2Flecainide (Tambocor)FDA LinkGeneric
03/2021 - 01/2021
2Rosuvastatin Calcium (Crestor)FDA Link
03/2021 - 01/2021
2UbiquinoneIBA
03/2021 - 01/2021
23' Untranslated Regions (3' UTR)IBA
01/2021 - 12/2018
2LipidsIBA
10/2020 - 11/2012
2Argininosuccinate Synthase (Argininosuccinate Synthetase)IBA
01/2020 - 01/2019
2AntigensIBA
01/2020 - 11/2018
2Glutathione (Reduced Glutathione)IBA
01/2020 - 01/2019
2HLA Antigens (Human Leukocyte Antigens)IBA
01/2020 - 11/2018
2TOR Serine-Threonine KinasesIBA
12/2019 - 11/2015
2Aspartic Acid (Aspartate)FDA Link
01/2019 - 11/2015
2Aspartate CarbamoyltransferaseIBA
01/2018 - 11/2015
2NitrogenIBA
01/2018 - 11/2015
2Carbamyl Phosphate (Carbamoyl Phosphate)IBA
01/2018 - 11/2015
2Tricarboxylic AcidsIBA
12/2015 - 01/2015
2FumaratesIBA
01/2015 - 08/2011
2Adenosine Triphosphate (ATP)IBA
08/2014 - 03/2011
1Tyrosine Kinase InhibitorsIBA
04/2024
1Rituximab (Mabthera)FDA Link
03/2024
1Myeloid Ecotropic Viral Integration Site 1 ProteinIBA
12/2023
1ChromatinIBA
12/2023
1immune RNA (I-RNA)IBA
12/2023
1Membrane Proteins (Integral Membrane Proteins)IBA
10/2023
1Adenosine (Adenocard)FDA LinkGeneric
10/2023
1C-Reactive ProteinIBA
10/2023
1P-2 (P 2)IBA
10/2023
1Interleukin-6 (Interleukin 6)IBA
10/2023
1Hematoxylin (Haematoxylon)IBA
09/2023
1Eosine Yellowish-(YS) (Eosin)IBA
09/2023

Therapy/Procedure

41Therapeutics
04/2024 - 06/2011
21Immunotherapy
11/2023 - 01/2018
2Chemoradiotherapy
01/2022 - 01/2020
2Injections
11/2021 - 01/2017